BiotechTube
Home/Amylyx Pharmaceuticals/Justin Klee
JK

Justin Klee

Co-Chief Executive Officer & President

Amylyx Pharmaceuticals

Therapeutic Areas

Neurodegenerative DiseasesRare Diseases

Amylyx Pharmaceuticals Pipeline

DrugIndicationPhase
RELYVRIO/ALBRIOZA (AMX0035)Amyotrophic Lateral Sclerosis (ALS)Approved/Commercial
AMX0035Amyotrophic Lateral Sclerosis (ALS)Phase 3
AMX0114Amyotrophic Lateral Sclerosis (ALS)Phase 1

Leadership Team at Amylyx Pharmaceuticals

JC
Joshua Cohen
Co-Chief Executive Officer & Chairman of the Board
JF
James Frates
Chief Financial Officer
MO
Margaret Olinger
Chief Commercial Officer
JM
Joseph M. Bosch
Chief Legal Officer and Corporate Secretary
CL
Camille L. Bedrosian, M.D.
Chief Medical Officer
PD
Patrick D. Yeramian, M.D.
Chief Development Officer
KD
Kelley Dupuis
Chief Operating Officer
GK
G. Kelly Martin
Board Member
DW
David W. Meline
Board Member
GM
Gina Mazzariello
Board Member
View full Amylyx Pharmaceuticals profile